Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.

{"article_title":"Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.","author":"El Tal T, Ryan ME, Feldman BM, Bingham CA, Burnham JM, Batthish M, Bullock D, Ferraro K, Gilbert M, Gillispie-Taylor M, Gottlieb B, Harris JG, Hazen M, Laxer RM, Lee TC, Lovell D, Mannion M, Noonan L, Oberle E, Taylor J, Weiss JE, Toruner CY, Morgan EM","journal_title":"The Journal of rheumatology","issn":"0315-162X","isbn":"","publication_date":"2022 May","volume":"49","issue":"5","first_page":"497","page_count":"","accession_number":"35105705","doi":"10.3899\/jrheum.210709","publisher":"Journal Of Rheumatology Publishing Co","doctype":"Journal Article","subjects":"Arthritis, Juvenile drug therapy; Rheumatology methods; Child; Consensus; Cost of Illness; Humans; Patient Participation","interest_area":["Orthopedic"," Pediatric Medicine"," Immunology Allergy & Inflammation"],"abstract":"Objective: Treat to target (T2T) is a strategy of adjusting treatment until a target is reached. An international task force recommended T2T for juvenile idiopathic arthritis (JIA) treatment. Implementing T2T in a standard and reliable way in clinical practice requires agreement on critical elements of (1) target setting, (2) T2T strategy, (3) identifying barriers to implementation, and (4) patient eligibility. A consensus conference was held among Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) stakeholders to inform a statement of understanding regarding the PR-COIN approach to T2T. Methods: PR-COIN stakeholders including 16 healthcare providers and 4 parents were invited to form a voting panel. Using the nominal group technique, 2 rounds of voting were held to address the above 4 areas to select the top 10 responses by rank order. Results: Incorporation of patient goals ranked most important when setting a treatment target. Shared decision making (SDM), tracking measurable outcomes, and adjusting treatment to achieve goals were voted as the top elements of a T2T strategy. Workflow considerations, and provider buy-in were identified as key barriers to T2T implementation. Patients with JIA who had poor prognostic factors and were at risk for high disease burden were leading candidates for a T2T approach. Conclusion: This consensus conference identified the importance of incorporating patient goals as part of target setting and of the influence of patient stakeholder involvement in drafting treatment recommendations. The network approach to T2T will be modified to address the above findings, including solicitation of patient goals, optimizing SDM, and better workflow integration. Copyright \ufffd 2022 by the Journal of Rheumatology.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35105705&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"El Tal T, Ryan ME, Feldman BM, Bingham CA, Burnham JM, Batthish M, Bullock D, Ferraro K, Gilbert M, Gillispie-Taylor M, Gottlieb B, Harris JG, Hazen M, Laxer RM, Lee TC, Lovell D, Mannion M, Noonan L, Oberle E, Taylor J, Weiss JE, Toruner CY, Morgan EM","Journal_Info":"Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE","Publication_Type":"Journal Article; Research Support, Non-U.S. Gov't","Published_Date":"2022-05-01","Source":"The Journal of rheumatology [J Rheumatol] 2022 May; Vol. 49 (5), pp. 497-503. Date of Electronic Publication: 2022 Feb 01.","Languages":"English","Electronic_ISSN":"1499-2752","MeSH_Terms":"Arthritis, Juvenile*\/drug therapy , Rheumatology*\/methods, Child ; Consensus ; Cost of Illness ; Humans ; Patient Participation","Subjects":"Child, Consensus, Cost of Illness, Humans, Patient Participation, Arthritis, Juvenile drug therapy, Rheumatology methods","Title_Abbreviations":"The Journal of rheumatology","Volume":"49"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35105705","RelevancyScore":"883","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"882.715515136719"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35105705&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35105705&authtype=shib&custid=ns346513&group=main&profile=eds"}